Company Nuevolution AB (publ)

NUE

SE0007730650

Pharmaceuticals

Business Summary

Share class

Company contact information

Sector

Sector Biopharmaceuticals

Delayed Nasdaq Stockholm Other stock markets			5-day change	1st Jan Change
- ^SEK	-.--%		-0.31%	+90.59%

2019	Amgen Inc. completed the acquisition of Nuevolution AB (OM:NUE) from Industrifonden, Skandinaviska Enskilda Banken AB (publ.) (OM:SEB A), Sunstone LSV Fund I K/S, SEB-Stiftelsen, Skandinaviska Enskilda Bankens Pensionsstiftelse, S-E-Bankens Utvecklingsstiftelse and others.	CI
2019	Nuevolution AB Reports Earnings Results for the First Quarter Ended of March 2019	CI

Nuevolution AB is a Sweden-based biopharmaceutical company working to develop future medicine for the treatment of cancer and inflammatory diseases. The Companyâs business is conducted through its wholly owned subsidiary, Nuevolution A/S.

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	49,525,000	45,052,569 ( 90.97 %)	0	90.97 %

Nuevolution AB

Rønnegade 8

2100, Copenhagen

+45 70 20 09 87

http://www.nuevolution.com

Healthcare

Pharmaceuticals & Medical Research

Pharmaceuticals

Pharmaceuticals

Biopharmaceuticals

	1st Jan change	Capi.
NUEVOLUTION AB (PUBL)	+90.59%	0
CSL LIMITED	-4.06%	86.13B
SAMSUNG BIOLOGICS CO.,LTD.	+1.32%	39.82B
BIOGEN INC.	-19.27%	30.42B
UCB	+56.34%	25.23B
BIOMARIN PHARMACEUTICAL INC.	-16.09%	15.36B
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD.	-9.14%	11.95B
INCYTE CORPORATION	-17.69%	11.6B
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD.	-43.00%	11.51B
SWEDISH ORPHAN BIOVITRUM AB	+6.37%	8.71B

Biopharmaceuticals